Integer Holdings (Integer Holdings) GF Value : $98.67 (As of Apr. 28, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-28), Integer Holdings's share price is $109.58. Integer Holdings's GF Value is $98.67. Therefore, Integer Holdings's Price-to-GF-Value for today is 1.11.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Integer Holdings is Modestly Overvalued.

Integer Holdings (NYSE:ITGR) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Integer Holdings's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	109.58	/	98.67
	=	1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integer Holdings GF Value Related Terms

Thank you for viewing the detailed overview of Integer Holdings's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Integer Holdings (Integer Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

WGB:Germany

Address

5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024

Website

https://www.integer.net

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

Executives

Donald J Spence	director	C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jean M. Hobby	director	10000 WEHRLE DRIVE, CLARENCE NY 14031
Jim Stephens	officer: President, CRM & Neuro	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith	officer: VP, Interim CFO	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic	director	1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey	director	1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn	officer: SVP, Strategy and Business Dev	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Marshall Mcalister C Ii	officer: SVP, Gen Counsel & Secretary	1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226
Margaret Carthy	officer: SVP, Quality & Regulatory Affa	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph F Flanagan	officer: EVP, Quality & Regulatory Affa	10000 WEHRLE DRIVE, CLARENCE NY 14031
Bill R Sanford	director	2617 BULRUSH LANE, NAPLES FL 34105
Anthony W Borowicz	officer: SVP Strategy,Corp Dev., IR	10000 WEHRLE DRIVE, CLARENCE NY 14031
Sheila Antrum	director	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024